Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-27 Sale |
2023-01-31 5:34 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $51.47 | $1,286,798 | 548,693 (Direct) |
View |
| 2022-12-28 Sale |
2022-12-30 5:33 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $40.93 | $1,023,290 | 573,693 (Direct) |
View |
| 2022-11-28 Sale |
2022-11-30 5:36 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $54.03 | $1,350,827 | 519,861 (Direct) |
View |
| 2022-10-26 Sale |
2022-10-28 5:43 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $54.81 | $1,370,191 | 558,612 (Direct) |
View |
| 2022-09-28 Sale |
2022-09-30 5:42 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $64.61 | $1,615,160 | 323,612 (Direct) |
View |
| 2022-08-29 Sale |
2022-08-31 5:45 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $66.84 | $1,671,084 | 348,612 (Direct) |
View |
| 2022-07-27 Sale |
2022-07-29 5:38 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $75.91 | $1,897,747 | 373,612 (Direct) |
View |
| 2022-06-29 Sale |
2022-07-01 6:00 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $61.59 | $1,539,862 | 298,612 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-21 Tax Withholding |
2023-02-22 5:38 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
6,373 | $48.26 | 415,738 (Direct) |
View |
| 2023-02-18 Exercise |
2023-02-22 5:38 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
13,250 | $0 | 415,738 (Direct) |
View |
| 2023-02-21 Tax Withholding |
2023-02-22 5:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
1,950 | $48.26 | 63,541 (Direct) |
View |
| 2023-02-18 Exercise |
2023-02-22 5:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
3,825 | $0 | 63,541 (Direct) |
View |
| 2023-01-27 Exercise |
2023-01-31 5:34 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $19.12 | 548,693 (Direct) |
View |
| 2023-01-27 Exercise |
2023-01-31 5:34 pm |
N/A 2027-12-01 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 548,693 (Direct) |
View |
| 2022-12-28 Exercise |
2022-12-30 5:33 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $19.12 | 573,693 (Direct) |
View |
| 2022-12-28 Exercise |
2022-12-30 5:33 pm |
N/A 2027-12-01 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 573,693 (Direct) |
View |
| 2022-12-06 Exercise |
2022-12-08 5:35 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
58,233 | $0 | 369,111 (Direct) |
View |
| 2022-12-06 Exercise |
2022-12-08 5:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
58,233 | $1.81 | 369,111 (Direct) |
View |
| 2022-12-05 Tax Withholding |
2022-12-06 5:49 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
19,401 | $52.26 | 310,878 (Direct) |
View |
| 2022-12-03 Exercise |
2022-12-06 5:49 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
40,000 | $0 | 310,878 (Direct) |
View |
| 2022-12-05 Tax Withholding |
2022-12-06 5:47 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
3,234 | $52.26 | 50,191 (Direct) |
View |
| 2022-12-03 Exercise |
2022-12-06 5:47 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
6,667 | $0 | 50,191 (Direct) |
View |
| 2022-11-28 Exercise |
2022-11-30 5:36 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $19.12 | 519,861 (Direct) |
View |
| 2022-11-28 Exercise |
2022-11-30 5:36 pm |
N/A 2027-12-01 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 519,861 (Direct) |
View |
| 2022-10-26 Exercise |
2022-10-28 5:43 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
19,582 | $16.21 | 558,612 (Direct) |
View |
| 2022-10-26 Exercise |
2022-10-28 5:43 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
5,418 | $19.12 | 558,612 (Direct) |
View |
| 2022-10-26 Exercise |
2022-10-28 5:43 pm |
N/A 2027-05-03 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 558,612 (Direct) |
View |
| 2022-10-14 Exercise |
2022-10-18 5:38 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer |
3,750 | $0 | 13,889 (Direct) |
View |
| 2022-10-17 Tax Withholding |
2022-10-18 5:38 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer |
1,111 | $55.76 | 13,889 (Direct) |
View |
| 2022-10-07 Option Award |
2022-10-12 5:42 pm |
N/A 2032-10-07 |
CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer |
14,000 | $0 | 14,000 (Direct) |
View |
| 2022-10-07 Option Award |
2022-10-12 5:41 pm |
N/A 2032-10-07 |
CRISPR Therapeutics AG | CRSP | Morrow Phuong Khanh Chief Medical Officer |
9,380 | $0 | 9,380 (Direct) |
View |
| 2022-10-07 Option Award |
2022-10-12 5:40 pm |
N/A 2032-10-07 |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
14,000 | $0 | 14,000 (Direct) |
View |
| 2022-09-28 Exercise |
2022-09-30 5:42 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $16.21 | 323,612 (Direct) |
View |
| 2022-09-28 Exercise |
2022-09-30 5:42 pm |
N/A 2027-05-03 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 323,612 (Direct) |
View |
| 2022-08-29 Exercise |
2022-08-31 5:45 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $16.21 | 348,612 (Direct) |
View |
| 2022-08-29 Exercise |
2022-08-31 5:45 pm |
N/A 2027-05-03 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 348,612 (Direct) |
View |
| 2022-08-16 Option Award |
2022-08-18 5:39 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-08-16 Option Award |
2022-08-18 5:37 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
175,000 | $0 | 175,000 (Direct) |
View |
| 2022-08-16 Option Award |
2022-08-18 5:36 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
12,500 | $0 | 12,500 (Direct) |
View |
| 2022-08-16 Option Award |
2022-08-18 5:33 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-07-27 Exercise |
2022-07-29 5:38 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
16,667 | $16.21 | 373,612 (Direct) |
View |
| 2022-07-27 Exercise |
2022-07-29 5:38 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
8,333 | $12.57 | 373,612 (Direct) |
View |
| 2022-07-27 Exercise |
2022-07-29 5:38 pm |
N/A 2026-07-15 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 373,612 (Direct) |
View |
| 2022-06-29 Exercise |
2022-07-01 6:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $12.57 | 298,612 (Direct) |
View |
| 2022-06-29 Exercise |
2022-07-01 6:00 pm |
N/A 2026-07-15 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 298,612 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:46 pm |
N/A 2032-06-09 |
CRISPR Therapeutics AG | CRSP | Behbahani Ali Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:44 pm |
N/A 2032-06-09 |
CRISPR Therapeutics AG | CRSP | Treco Douglas A Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:43 pm |
N/A 2032-06-09 |
CRISPR Therapeutics AG | CRSP | High Katherine A Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:41 pm |
N/A 2032-06-09 |
CRISPR Therapeutics AG | CRSP | Greene John Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:39 pm |
N/A 2032-06-09 |
CRISPR Therapeutics AG | CRSP | George Simeon Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:37 pm |
N/A 2032-06-09 |
CRISPR Therapeutics AG | CRSP | Fardis Maria Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:36 pm |
N/A 2032-06-09 |
CRISPR Therapeutics AG | CRSP | Fleming Harold Edward Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:35 pm |
N/A 2032-06-09 |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-05-23 Option Award |
2022-05-24 5:55 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Morrow Phuong Khanh Chief Medical Officer |
117,750 | $0 | 117,750 (Direct) |
View |
| 2022-03-14 Tax Withholding |
2022-03-14 6:12 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
4,153 | $61.08 | 329,112 (Direct) |
View |
| 2022-03-11 Tax Withholding |
2022-03-14 6:12 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
5,487 | $62.56 | 329,112 (Direct) |
View |
| 2022-03-10 Exercise |
2022-03-14 6:12 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,834 | $0 | 329,112 (Direct) |
View |
| 2022-03-14 Tax Withholding |
2022-03-14 6:03 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
1,229 | $61.08 | 40,380 (Direct) |
View |
| 2022-03-11 Tax Withholding |
2022-03-14 6:03 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
1,883 | $62.56 | 40,380 (Direct) |
View |
| 2022-03-10 Exercise |
2022-03-14 6:03 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
7,584 | $0 | 40,380 (Direct) |
View |
| 2022-03-14 Tax Withholding |
2022-03-14 6:01 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
1,039 | $61.08 | 56,012 (Direct) |
View |
| 2022-03-11 Tax Withholding |
2022-03-14 6:01 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
1,321 | $62.56 | 56,012 (Direct) |
View |
| 2022-03-10 Exercise |
2022-03-14 6:01 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
5,084 | $0 | 56,012 (Direct) |
View |
| 2022-02-18 Option Award |
2022-02-22 5:44 pm |
N/A 2032-02-18 |
CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer |
45,300 | $0 | 45,300 (Direct) |
View |
| 2022-02-18 Option Award |
2022-02-22 5:43 pm |
N/A 2032-02-18 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
168,000 | $0 | 168,000 (Direct) |
View |
| 2022-02-18 Option Award |
2022-02-22 5:41 pm |
N/A 2032-02-18 |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
66,600 | $0 | 66,600 (Direct) |
View |
| 2022-02-18 Option Award |
2022-02-22 5:40 pm |
N/A 2032-02-18 |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
49,500 | $0 | 49,500 (Direct) |
View |
| 2021-12-20 Exercise |
2021-12-22 8:00 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
17,750 | $0 | 337,318 (Direct) |
View |
| 2021-12-20 Exercise |
2021-12-22 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
17,750 | $1.81 | 337,318 (Direct) |
View |